| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALNYLAM PHARMACEUTICALS INC | 832,549 | 46,198,000 | 15.78% | ||
| 2 | INCYTE | 392,236 | 31,371,000 | 10.72% | ||
| 3 | BLUEBIRD BIO INCORPORATED | 612,025 | 26,495,000 | 9.05% | ||
| 4 | ACHILLION PHARMACEUTICALS INC COM | 2,424,136 | 18,908,000 | 6.46% | ||
| 5 | LA JOLLA PHARMACEUTICAL CO | 1,176,146 | 18,818,000 | 6.43% | ||
| 6 | AVEXIS INC COM | 476,367 | 18,111,000 | 6.19% | ||
| 7 | BRISTOL MYERS SQUIBB CO | 209,701 | 15,424,000 | 5.27% | ||
| 8 | KITE PHARMA INCORPORATED | 285,518 | 14,276,000 | 4.88% | ||
| 9 | SYMMETRY SURGICAL INC | 922,215 | 12,109,000 | 4.14% | ||
| 10 | SPDR GOLD TR | 83,000 | 10,497,000 | 3.59% | ||
| 11 | Atara Biotherapeutics Inc | 465,874 | 10,487,000 | 3.58% | ||
| 12 | AGENUS INC | 2,429,149 | 9,838,000 | 3.36% | ||
| 13 | BIOCRYST PHARMACEUTICALS | 2,237,066 | 6,353,000 | 2.17% | ||
| 14 | ISHARES TR | 45,000 | 6,251,000 | 2.14% | ||
| 15 | Dicerna Pharmaceuticals | 2,026,894 | 6,081,000 | 2.08% | ||
| 16 | INTERCEPT PHARMACEUTICAL | 39,500 | 5,636,000 | 1.93% | ||
| 17 | CELLDEX THERAPEUTICS INC NEW | 1,264,227 | 5,550,000 | 1.90% | ||
| 18 | OMEROS CORP | 526,788 | 5,542,000 | 1.89% | ||
| 19 | Viveve Medical Inc | 814,946 | 3,341,000 | 1.14% | ||
| 20 | BARCLAYS BANK PLC | 144,200 | 3,194,000 | 1.09% | ||
| 21 | CORIUM INTERNATIONAL INC | 852,961 | 2,960,000 | 1.01% | ||
| 22 | INVUITY INC | 226,042 | 2,154,000 | 0.74% | ||
| 23 | REGENXBIO INC COM | 242,784 | 1,942,000 | 0.66% | ||
| 24 | FIVE PRIME THERAPEUTICS INC | 44,701 | 1,848,000 | 0.63% | ||
| 25 | GLOBAL BLOOD THERAPEUTICS IN COM | 97,138 | 1,612,000 | 0.55% | ||
| 26 | MASIMO CORP COM | 25,900 | 1,360,000 | 0.46% | ||
| 27 | ACCELERATE DIAGNOSTICS INC | 74,843 | 1,077,000 | 0.37% | ||
| 28 | CYTRX CORP | 466,200 | 1,040,000 | 0.36% | ||
| 29 | SENSUS HEATLHCARE INC | 155,000 | 1,006,000 | 0.34% | ||
| 30 | MANNKIND CORPORATION | 4,385 | 912,000 | 0.31% | Put | |
| 31 | MIRATI THERAPEUTICS INC COM | 131,052 | 716,000 | 0.24% | ||
| 32 | ALLSCRIPTS HEALTHCARE | 48,000 | 610,000 | 0.21% | ||
| 33 | BIOPHARMX CORP COM | 700,636 | 455,000 | 0.16% | ||
| 34 | NATERA INC | 31,693 | 382,000 | 0.13% | ||
| 35 | Nivalis Therapeutics Inc | 30,000 | 138,000 | 0.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-16-012354, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
